2,519
Views
1
CrossRef citations to date
0
Altmetric
Arctic Military Conference in Cold Weather Medicine

Iloprost for the treatment of frostbite: a scoping review

, &
Article: 2189552 | Received 01 Jan 2023, Accepted 07 Mar 2023, Published online: 26 Mar 2023

References

  • Handford C, Thomas O, Imray CHE. Frostbite. Emerg Med Clin North Am. 2017;35(2):281–15.
  • McIntosh SE, Freer L, Grissom CK, et al. Wilderness medical society clinical practice guidelines for the prevention and treatment of frostbite: 2019 update. Wilderness Environ Med. 2019;30(4S):S19–32.
  • Cauchy E, Chenille E, Marchand V, et al. Retrospective study of 70 cases of severe frostbite lesions: a proposed new classification scheme. Wilderness Environ Med. 2001;12(4):248–255.
  • Drinane J, Kotamarti VS, O’connor C, et al. Thrombolytic salvage of threatened frostbitten extremities and digits: a systematic review. J Burn Care Res. 2019;40(5):541–549.
  • Drinane J, Heiman AJ, Ricci JA, et al. Thrombolytic salvage of the frostbitten upper extremity: a systematic review. Hand (N Y). 2022;17(3):397–404. doi:10.1177/1558944720940065
  • Mills WJ, Whaley R, Fish W. Frostbite: experience with rapid rewarming and ultrasonic therapy. Part III. 1961. Alaska Med. 1993;35(1): 19–27. Part III. 1961.
  • Robson MC, Heggers JP. Evaluation of hand frostbite blister fluid as a clue to pathogenesis. J Hand Surg Am. 1981;6(1):43–47.
  • Heggers JP, Robson MC, Manavalen K, et al. Experimental and clinical observations on frostbite. Ann Emerg Med. 1987;16(9):1056–1062.
  • McCauley RL, Hing DN, Robson MC, et al. Frostbite injuries: a rational approach based on the pathophysiology. J Trauma. 1983;23(2):143–147. doi:10.1097/00005373-198302000-00013
  • Heggers JP, Phillips LG, McCauley RL, et al. Frostbite: experimental and clinical evaluations of treatment. J Wilderness Med. 1990;1(1):27–32. doi:10.1580/0953-9859-1.1.27
  • McCauley RL, Heggers JP, Robson MC. Frostbite. Postgrad Med. 1990;88(8):67–77.
  • Skolnick AA. Early data suggest clot-dissolving drug may help save frostbitten limbs from amputation. JAMA. 1992;267(15):2008–2010.
  • Murphy J, Endorf FW, Winters MK, et al. Bleeding complications in patients with severe frostbite injury. J Burn Care Res. 2022;irac180. doi:10.1093/jbcr/irac180.
  • Hutchison RL, Miller HM, Michalke SK. The use of tPA in the treatment of frostbite: a systematic review. Hand (N Y). 2019;14(1):13–18.
  • Nygaard RM, Lacey AM, Lemere A, et al. Time matters in severe frostbite: assessment of Limb/digit salvage on the individual patient level. J Burn Care Res. 2017;38(1):53–59.
  • Cutlip D, Lincoff AM. Anticoagulant therapy in non-ST elevation acute coronary syndromes. In: Verheugt F, editor. UpToDate. Waltham (MA): Wolters Kluwer N.V.; 2022.
  • Levien TL. Advances in the treatment of Raynaud’s phenomenon. Vasc Health Risk Manag. 2010;6:167–177.
  • Robertson L, Andras A. Prostanoids for intermittent claudication. Cochrane Database Syst Rev. 2013;(4). CD000986. doi:10.1002/14651858.CD000986.pub3
  • Vietto V, Franco JV, Saenz V, et al. Prostanoids for critical limb ischaemia. Cochrane Database Syst Rev. 2018;1(1). CD006544. doi:10.1002/14651858.CD006544.pub3
  • Cacione DG, Macedo CR, Do Carmo Novaes F, et al. Pharmacological treatment for Buerger’s disease. Cochrane Database Syst Rev. 2020;5(5):CD011033.
  • Groechenig E. Treatment of frostbite with iloprost. Lancet. 1994;344(8930):1152–1153.
  • Weissman G. Prostaglandins in acute inflammation current concepts. Kalamazoo, Michigan: Scope Publication. The Upjohn Company; 1980.
  • Grant SM, Goa KI. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures. Drugs. 1992;43(6):889–924.
  • Cotran RS, Kumar V, Collins T. Robbins pathologic basis of disease. 6th ed ed. Philadelphia, PA: Elsevier Science; 1999.
  • Bixio R, Adami G, Bertoldo E, et al. Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis. Ther Adv Musculoskelet Dis. 2022;14:1759720X221137125.
  • Legrand M, Oufella HA, De Backer D, et al. I-MICRO trial investigators. The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial-study protocol for a randomized controlled trial. Trials. 2020;21(1):601.
  • Cristo Ropero MJ, Cruz-Utrilla A, Escribano-Subias MP. Epoprostenol for the treatment of pulmonary arterial hypertension. Expert Rev Clin Pharmacol. 2021;14(8):1005–1013.
  • The Institute for Safe Medication Practices Canada (ISMP Canada). Alert: interruption of epoprostenol (flolan) infusion leads to patient’s death. ISMP Canada Safety Bulletins. 2011;11(2): [Accessed December 22, 2022]; Available online at. https://ismpcanada.ca/bulletin/alert-interruption-of-epoprostenol-flolan-infusion-leads-to-patients-death/
  • Cruz JE, Ward A, Anthony S, et al. Evidence for the use of epoprostenol to treat raynaud’s phenomenon with or without digital ulcers. Ann Pharmacother. 2016;50(12):1060–1067.
  • Khan SL, Parikh R, Mooncai T, et al. Barriers to frostbite treatment at an academic medical center. Am J Emerg Med. 2019;37(8):.e1601.3–1601.5.
  • Eslami Do A, Lauver B. Utilization of epoprostenol in the management of severe frostbite. CHEST Annual Meeting, Medical Student/resident Case Report Posters. Chicago, IL, USA; October 23 2019; (Abstract). doi:10.1016/j.chest.2019.08.2054
  • Bello JW, Rickrode GA, Harlan NP, et al. Systemic prostacyclin analogues for frostbite require careful monitoring. J Burn Care Res. 2022;44(2):irac178. doi:10.1093/jbcr/irac178
  • Woo EK, Lee JW, Hur GY, et al. Proposed treatment protocol for frostbite: a retrospective analysis of 17 cases based on a 3-year single-institution experience. Arch Plast Surg. 2013;40(5):510–516.
  • Patel N, Srinivasa DR, Srinivasa RN, et al. Intra-arterial thrombolysis for extremity frostbite decreases digital amputation rates and hospital length of stay. Cardiovasc Intervent Radiol. 2017;40(12):1824–1831.
  • Zhang N, Yu X, Zhao J, et al. Management and outcome of feet deep frostbite injury (III and IV degrees): a series report of 36 cases. Int J Low Extrem Wounds. 2022;21(3):325–331.
  • Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-Scr): checklist and explanation. Ann Intern Med. 2018;169(7):467–473.
  • Peters MDJ, Marnie C, Tricco AC, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18(10):2119–2126.
  • Hödl S. Zur Therapie der Erfrierungen [Treatment of freezing injury]. Wien Med Wochenschr. 2005;1551:199–203. [German]. doi:10.1007/s10354-005-0165-5
  • Roche-Nagle G, Murphy D, Collins A, et al. Frostbite: management options. Eur J Emerg Med. 2008;15(3):173–175.
  • Imray C, Grieve A, Dhillon S, et al. Cold damage to the extremities: frostbite and non-freezing cold injuries. Postgrad Med J. 2009;85(1007):481–488.
  • Cauchy E, Cheguillaume B, Chetaille E. A controlled trial of a prostacyclin and rt-PA in the treatment of severe frostbite. N Engl J Med. 2011;364(2):189–190.
  • Gorjanc J, Ahčan UG, Veselko M, et al. Modern management of patients with frostbite. ZdravVestn. 2012;81(10). Accessed on December 30, 2022. [Slovenian] Available from. https://vestnik.szd.si/index.php/ZdravVest/article/view/599
  • Haik J, Brown S, Liran A, et al. Deep Frostbite: the question of adjuvant treatment. Isr Med Assoc J. 2016;18(1):56–57.
  • Cauchy E, Chetaille E, Pham E, et al. Iloprost with and without rt-PA: treatment of 131 cases of severe frostbite. 7th World Congress of Mountain and Wilderness Med. Telluride, Colorado. July 30 - August 4. 2016;273: 432. (Abstract). doi:10.1016/j.wem.2016.06.029
  • Poole A, Gauthier J. Treatment of severe frostbite with iloprost in northern Canada. CMAJ. 2016;188(17–18):1255–1258.
  • Lindford A, Valtonen J, Hult M, et al. The evolution of the Helsinki frostbite management protocol. Burns. 2017;43(7):1455–1463. doi:10.1016/j.burns.2017.04.016
  • Pandey P, Vadlamudi R, Pradhan R, et al. Case report: severe frostbite in extreme altitude climbers-the Kathmandu iloprost experience. Wilderness Environ Med. 2018;29(3):366–374.
  • Gorjanc J, Mekjavic I, Havlicek T, et al. The planica protocol for frostbite management - 2 case reports. XII international society for mountain medicine world congress on mountain medicine. Kathmandu, Nepal; November 21–24 2018. Abstract 33861. doi:10.1089/ham.2018.29015.abstracts
  • Irarrazaval S, Besa P, Cauchy E, et al. Case report of frostbite with delay in evacuation: field use of iloprost might have improved the outcome. High Alt Med Biol. 2018;19(4):382–387.
  • Jud P, Hafner F, Brodmann M. Frostbite of the hands after paragliding: a chilling experience. Lancet. 2019;394(10216):2282.
  • Lorenzo-Villalba N, Andres E, Guerrero-Niño J, et al. Frostbite and cold agglutinin disease: coexistence of two entities leading to poor clinical outcomes. Medicina (Kaunas). 2021;57(6):592.doi:10.3390/medicina57060592
  • Poole A, Gauthier J, MacLennan M. Management of severe frostbite with iloprost, alteplase and heparin: a Yukon case series. CMAJ Open. 2021;9(2):E585–591.
  • MacLennan M, Poole A, Gauthier J. Use of fluorescence to visualize response to iloprost treatment for frostbite. CMAJ. 2021;193(31):E1219.
  • Magnan M-A, Gavet-Ageron A, Louge P, et al. Hyperbaric oxygen therapy with iloprost improves digit salvage in severe frostbite compared to iloprost alone. Medicina (Kaunas). 2021;57(11):1284.
  • Magnan DM, Gelsomino M, Louge P, et al. Successful delayed hyperbaric oxygen therapy and iloprost treatment on severe Frostbite at high altitude. High Alt Med Biol. 2022;23(3):294–297.
  • Crooks S, Shaw BH, Andruchow JE, et al. Effectiveness of intravenous prostaglandin to reduce digital amputations from frostbite: an observational study. CJEM. 2022;24(6):622–629.
  • Cauchy E, Davis CB, Pasquier M, et al. A new proposal for management of severe frostbite in the austere environment. Wilderness Environ Med. 2016;27(1):92–99.
  • European Union Clinical Trials Register. Prospective randomised non-inferiority Nordic frostbite treatment study comparing tPA and iloprost therapy. (Ongoing). EudraCT Number: 2018-000712-15. Available online at: https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-000712-15 (Accessed December 27, 2022).
  • Nygaard RM, Whitley AB, Fey RM, et al. The Hennepin score: quantification of frostbite management efficacy. J Burn Care Res. 2016;37(4):e317–22.
  • Regli IB, Strapazzon G, Falla M, et al. Long-term sequelae of frostbite-a scoping review. Int J Environ Res Public Health. 2021;18(18):9655.